Dose modification for safe treatment of a compound complex heterozygous DPYD variant carrier with 5-fluorouracil

JCO Precis Oncol. 2018:2:PO.18.00179. doi: 10.1200/po.18.00179. Epub 2018 Oct 3.

Authors

Shikshya Shrestha¹, Erin E Tapper¹, Colbren Scout Trogstad-Isaacson¹, Timothy J Hobday^{2

3}, Steven M Offer^{1

2

4}, Robert B Diasio^{1

2

4}

Affiliations

¹ Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.
² Mayo Clinic College of Medicine, Rochester, MN 55905 USA.
³ Department of Medical Oncology, Mayo Clinic, Rochester, MN 55905 USA.
⁴ Mayo Clinic Cancer Center, Rochester, MN 55905 USA.

No abstract available

Grants and funding